{'fraction_non_alphanumeric': 0.018867924528301886, 'fraction_numerical': 0.006003430531732418, 'mean_word_length': 5.946428571428571, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Investigating the determinants of patent acquisition in biotechnology: an empirical analysis

Acquiring patents is an increasingly relevant opportunity for innovating companies, especially after the rise and development of the so-called markets for technologies (MFTs). However, only scant attention has been devoted to investigate patents' characteristics influencing their acquisition by organisations. Accordingly, this paper aims at filling this gap by analysing how four main characteristics – as patent scope, scientific knowledge cited by the patent, forward patent citations, and number of patent claims – impact the likelihood of patent acquisition. We based our statistical analysis on a sample of 9716 US Patent and Trademark Office patents assigned to 165 biotechnological firms. Results support our conjectures and offer interesting managerial implications for organisations operating within MFTs indicating which characteristics make patented technological solutions more likely to be acquired by other firms, as a narrow scope, inclusion of scientific knowledge, and a number of forward citations able to increase patent's impact and exclusion rights.